Loading…
Invest in Women's Health Act of 2017
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 3,805 other S bills in the 115th — cohort avg 41d
Invest in Women's Health Act of 2017 This bill amends the Public Health Service Act to authorize the Department of Health and Human Services (HHS) to provide support to public or nonprofit entities to expand certain preventive health services, with an emphasis on increasing access to cancer screening, particularly for women of color. The bill reauthorizes through FY2020: (1) programs related to breast and gynecologic cancers under Medicaid and family planning programs, and (2) the Centers for Disease Control and Prevention's National Breast and Cervical Cancer Early Detection Program. HHS must establish a demonstration grant program to train health care providers regarding breast and gynecologic cancer screening. HHS must study and report on access to women's preventive cancer screening, including cancer rates by state, cancer screening by state, and estimated federal savings achieved through early detection of breast and gynecologic cancer.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (4)
2018 · fourth_quarter · Health Issues
H.R.930/S.497, Lymphedema Treatment Act, support Medicare coverage of certain lymphedema compression treatment items as durable medical equipment; H.R.1676/S.693, Palliative Care and Hospice Education and Training Act, support federal funding for research, training, education and awareness into palliative care; H.R.2307, Protecting Access to Lifesaving Screenings Act (PALS Act), advocate for continued access to and coverage for screening mammography; H.R.4122/S.2006, Breast Density and Mammography Reporting Act, issues related to the information provided to women and doctors on breast density and the potential impact it has on the detection of breast cancer and require the FDA to utilize up to date medical information and direct HHS to focus research on the best screening methods for breast tissue; S.1045, Save Womens Preventive Care Act, and S.689, Invest in Womens Health Act, protecting access to breast cancer screenings. S.91, Mobile Mammography Promotion Act, advocate for mobile mammography units to purchase fuel without the federal excise tax. H.R.1017, Removing Barriers to Colorectal Cancer Screening Act. Clinical trial policy.
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $60,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
2018 · third_quarter · Health Issues
H.R.930/S.497, Lymphedema Treatment Act, support Medicare coverage of certain lymphedema compression treatment items as durable medical equipment; H.R.1676/S.693, Palliative Care and Hospice Education and Training Act, support federal funding for research, training, education and awareness into palliative care; H.R.2307, Protecting Access to Lifesaving Screenings Act (PALS Act), advocate for continued access to and coverage for screening mammography; H.R.4122/S.2006, Breast Density and Mammography Reporting Act, issues related to the information provided to women and doctors on breast density and the potential impact it has on the detection of breast cancer and require the FDA to utilize up to date medical information and direct HHS to focus research on the best screening methods for breast tissue; S.1045, Save Womens Preventive Care Act, and S.689, Invest in Womens Health Act, protecting access to breast cancer screenings. S.91, Mobile Mammography Promotion Act, advocate for mobile mammography units to purchase fuel without the federal excise tax. H.R.1017, Removing Barriers to Colorectal Cancer Screening Act. Clinical trial policy.
Client expense: $70,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
2018 · third_quarter · Health Issues
Invest in Women's Health Act of 2017 (S. 689) Jeanette Acosta Invest in Women's Health Act of 2018 (H.R. 6315) Maternal Care Access and Reducing Emergencies Act (S. 3363) SUPPORT for Patients and Communities Act (H.R. 6) Preventing Maternal Deaths Act of 2018 (H.R. 1318) Increasing Access to Lower Premium Plans and Expanding Health Savings Account Act (H.R. 6311)
Client expense: $377,532 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · second_quarter · Health Issues
H.R.930/S.497, Lymphedema Treatment Act, support Medicare coverage of certain lymphedema compression treatment items as durable medical equipment; H.R.1676/S.693, Palliative Care and Hospice Education and Training Act, support federal funding for research, training, education and awareness into palliative care; H.R.2307, Protecting Access to Lifesaving Screenings Act (PALS Act), advocate for continued access to and coverage for screening mammography; H.R.4122/S.2006, Breast Density and Mammography Reporting Act, issues related to the information provided to women and doctors on breast density and the potential impact it has on the detection of breast cancer and require the FDA to utilize up to date medical information and direct HHS to focus research on the best screening methods for breast tissue; S.1045, Save Womens Preventive Care Act, and S.689, Invest in Womens Health Act, protecting access to breast cancer screenings. S.91, Mobile Mammography Promotion Act, advocate for mobile mammography units to purchase fuel without the federal excise tax. Clinical trial policy.
Client expense: $60,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
2018 · second_quarter · Health Issues
Invest in Women's Health Act of 2017 (S. 689) Jeanette Acosta Invest in Women's Health Act (H.R. 6315) Women's Health Protection Act (H.R. 1322/S. 510)
Client expense: $18,277 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · second_quarter · Health Issues
Invest in Women's Health Act of 2017 (S. 689) Jeanette Acosta Invest in Women's Health Act (H.R. 6315) Women's Health Protection Act (H.R. 1322/S. 510)
Client expense: $11,527 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · second_quarter · Health Issues
A resolution supporting the goals, activities, and ideals of Prematurity Awareness Month (H. Res. 625/S. Res. 319) Maternal Health Accountability Act (H.R. 1318/S. 1112) Invest in Women's Health Act of 2017 (S. 689) Helping to End Addiction and Lessen (HEAL) Substance Use Disorders Act (S. 3120) CREATES Act (H.R. 2212/S. 974) MOMMA's Act (H.R. 5977) State-Based Universal Health Care Act (H.R. 6097) SUPPORT for Patients and Communities Act (H.R. 6) Jeanette Acosta Invest in Women's Health Act (H.R. 6315) Health Equity and Accountability Act (H.R. 5942) Women's Health Protection Act (H.R. 1322/S. 510) A resolution recognizing the importance of the goal of National Women's Health Week to empower adolescent girls and women of all ages to make informed choices about their sexual activity and effective steps to prevent against HIV (S. Res. 507)
Client expense: $421,508 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · first_quarter · Health Issues
Nomination of Alex Michael Azar II, of Indiana, to be Secretary of Health and Human Services (P.N. 1371) Invest in Women's Health Act of 2017 (S. 689) Premium Relief Act of 2017 (H.R. 4666)
Client expense: $120,901 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · first_quarter · Health Issues
H.R.1409, Cancer Drug Coverage Parity Act, advocate to require insurance companies cover iv-administered and orally-administered anti-cancer drugs at the same cost to patients. H.R.930/S.497, Lymphedema Treatment Act, support Medicare coverage of certain lymphedema compression treatment items as durable medical equipment; H.R.1676/S.693, Palliative Care and Hospice Education and Training Act, support federal funding for research, training, education and awareness into palliative care; H.R.2307, Protecting Access to Lifesaving Screenings Act (PALS Act), advocate for continued access to and coverage for screening mammography; H.R.2999, Patients Access to Treatment Act, advocate for access to cancer therapies; H.R.4122/S.2006, Breast Density and Mammography Reporting Act, issues related to the information provided to women and doctors on breast density and the potential impact it has on the detection of breast cancer and require the FDA to utilize up to date medical information and direct HHS to focus research on the best screening methods for breast tissue; S.1045, Save Womens Preventive Care Act, and S.689, Invest in Womens Health Act, protecting access to breast cancer screenings. S.91, Mobile Mammography Promotion Act, advocate for mobile mammography units to purchase fuel without the federal excise tax.
Client expense: $130,000 · Firm income: Not reported
2017 · fourth_quarter · Health Issues
P.L.111-148, Patient Protection and Affordable Care Act, matters related to the Implementation of breast health education, research and clinical trials. H.R.1409, Cancer Drug Coverage Parity Act, advocate to require insurance companies cover iv-administered and orally-administered anti-cancer drugs at the same cost to patients. H.R.1628, American Health Care Act, advocate for inclusion of patient protections. H.R.930/S.497, Lymphedema Treatment Act, support Medicare coverage of certain lymphedema compression treatment items as durable medical equipment; H.R.1676/S.693, Palliative Care and Hospice Education and Training Act, support federal funding for research, training, education and awareness into palliative care; H.R.2307, Protecting Access to Lifesaving Screenings Act (PALS Act), advocate for continued access to and coverage for screening mammography; H.R.2999, Patients Access to Treatment Act, advocate for access to cancer therapies; H.R.4122/S.2006, Breast Density and Mammography Reporting Act, issues related to the information provided to women and doctors on breast density and the potential impact it has on the detection of breast cancer and require the FDA to utilize up to date medical information and direct HHS to focus research on the best screening methods for breast tissue; S.1045, Save Womens Preventive Care Act, and S.689, Invest in Womens Health Act, protecting access to breast cancer screenings. S.91, Mobile Mammography Promotion Act, advocate for mobile mammography units to purchase fuel without the federal excise tax.
Client expense: $50,000 · Firm income: Not reported
2017 · third_quarter · Health Issues
P.L.111-148, Patient Protection and Affordable Care Act, matters related to the Implementation of breast health education, research and clinical trials. H.R.1409, Cancer Drug Coverage Parity Act, advocate to require insurance companies cover iv-administered and orally-administered anti-cancer drugs at the same cost to patients. H.R.1628, American Health Care Act, advocate for inclusion of patient protections. H.R.930/S.497, Lymphedema Treatment Act, support Medicare coverage of certain lymphedema compression treatment items as durable medical equipment; H.R.1676/S.693, Palliative Care and Hospice Education and Training Act, support federal funding for research, training, education and awareness into palliative care; H.R.2307, Protecting Access to Lifesaving Screenings Act (PALS Act), advocate for continued access to and coverage for screening mammography; H.R.2999, Patients Access to Treatment Act, advocate for access to cancer therapies; S.1045, Save Womens Preventive Care Act, and S.689, Invest in Womens Health Act, protecting access to breast cancer screenings. S.91, Mobile Mammography Promotion Act, advocate for mobile mammography units to purchase fuel without the federal excise tax.
Client expense: $47,535 · Firm income: Not reported
2017 · second_quarter · Health Issues
P.L.111-148, Patient Protection and Affordable Care Act, matters related to the Implementation of breast health education, research and clinical trials. H.R.1409, Cancer Drug Coverage Parity Act, advocate to require insurance companies cover iv-administered and orally-administered anti-cancer drugs at the same cost to patients. H.R.1628, American Health Care Act, advocate for inclusion of patient protections. H.R.930/S.497, Lymphedema Treatment Act, support Medicare coverage of certain lymphedema compression treatment items as durable medical equipment; H.R.1676/S.693, Palliative Care and Hospice Education and Training Act, support federal funding for research, training, education and awareness into palliative care; H.R.2307, Protecting Access to Lifesaving Screenings Act (PALS Act), advocate for continued access to and coverage for screening mammography; H.R.2999, Patients Access to Treatment Act, advocate for access to cancer therapies; S.1045, Save Womens Preventive Care Act, and S.689, Invest in Womens Health Act, protecting access to breast cancer screenings.
Client expense: $54,630 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
2017 · second_quarter · Health Issues
P.L.111-148, Patient Protection and Affordable Care Act, matters related to the Implementation of breast health education, research and clinical trials. H.R.1409, Cancer Drug Coverage Parity Act, advocate to require insurance companies cover iv-administered and orally-administered anti-cancer drugs at the same cost to patients. H.R.1628, American Health Care Act, advocate for inclusion of patient protections. H.R.930/S.497, Lymphedema Treatment Act, support Medicare coverage of certain lymphedema compression treatment items as durable medical equipment; H.R.1676/S.693, Palliative Care and Hospice Education and Training Act, support federal funding for research, training, education and awareness into palliative care; H.R.2307, Protecting Access to Lifesaving Screenings Act (PALS Act), advocate for continued access to and coverage for screening mammography; H.R.2999, Patients Access to Treatment Act, advocate for access to cancer therapies; S.1045, Save Womens Preventive Care Act, and S.689, Invest in Womens Health Act, protecting access to breast cancer screenings.
Client expense: $54,630 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
2017 · second_quarter · Health Issues
P.L.111-148, Patient Protection and Affordable Care Act, matters related to the Implementation of breast health education, research and clinical trials. H.R.1409, Cancer Drug Coverage Parity Act, advocate to require insurance companies cover iv-administered and orally-administered anti-cancer drugs at the same cost to patients. H.R.1628, American Health Care Act, advocate for inclusion of patient protections. H.R.930/S.497, Lymphedema Treatment Act, support Medicare coverage of certain lymphedema compression treatment items as durable medical equipment; H.R.1676/S.693, Palliative Care and Hospice Education and Training Act, support federal funding for research, training, education and awareness into palliative care; H.R.2307, Protecting Access to Lifesaving Screenings Act (PALS Act), advocate for continued access to and coverage for screening mammography; H.R.2999, Patients Access to Treatment Act, advocate for access to cancer therapies; S.1045, Save Womens Preventive Care Act, and S.689, Invest in Womens Health Act, protecting access to breast cancer screenings.
Client expense: $54,630 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
2017 · second_quarter · Health Issues
ACA implementation; HR 1409 Cancer Drug Coverage Parity Act; HR 1313 Preserving Employee Wellness Programs Act; HR 1628 American Health Care Act; Better Care Reconciliation Act; HR 2999 Patients' Access to Treatment Act; S 1045 Save Women's Preventive Care Act; S 689 Invest in Women's Health Act
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2017 · first_quarter · Health Issues
Born Alive Abortion Survivors Protection Act (H.R. 37/S. 220) Allowing Greater Access to Safe and Effective Contraception Act (H.R. 421/S. 93) Women Veterans Access to Quality Care Act (S. 471) American Health Care Act (H.R. 1628) Providing for consideration of the bill (H.R. 1628) to provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017 (H. Res. 228) Providing for further consideration of the bill (H.R. 1628) to provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017 (H. Res. 254) Invest in Women's Health Act of 2017 (S. 689) Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the final rule submitted by Secretary of Health and Human Services relating to compliance with title X requirements by project recipients in selecting subrecipients (H.J. Res. 43/S.J. Res. 13) Title X Abortion Provider Prohibition Act (H.R. 217) Defund Planned Parenthood Act of 2017 (H.R. 354) Protect Funding for Women's Health Care Act (S. 241) Nomination of Scott Gottlieb, of Connecticut, to be Commissioner of Food and Drugs, Department of Health and Human Services (P.N. 118) Nomination of Thomas Price, of Georgia, to be Secretary of Health and Human Services (P.N. 33)
Client expense: $444,877 · Firm income: Not reported
2017 · first_quarter · Health Issues
American Health Care Act (H.R. 1628) Invest in Women's Health Act of 2017 (S. 689) Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the final rule submitted by Secretary of Health and Human Services relating to compliance with title X requirements by project recipients in selecting subrecipients (H.J. Res. 43/S.J. Res. 13) Nomination of Thomas Price, of Georgia, to be Secretary of Health and Human Services (P.N. 33)
Client expense: $137,648 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
| Democratic |
| WI |
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE